Q&A: AI in diabetes care poses many challenges, benefits to patients and clinicians AI in diabetes care is becoming more popular with various potential benefits for patients and clinicians as well as important challenges to keep in mind, according to a conversation between two diabetes experts
Wegovy is a well-established option with strong insurance coverage across many plans
Guan R, Yang Q, Yang X, Du W, Li X, Ma G
The key is to avoid positioning it as an equal alternative in effectiveness
(Shows semaglutide + progestin synergy and upregulation of progesterone receptors in endometrial models.) PubMed+1 Bourou MZ, et al
If youve recently started tirzepatide or are considering it, you may wonder: How long until I see results